[1]
“Rapid & Low-Cost DPYD Genotyping to Guide Fluoropyrimidine Treatment in Cancer Patients”, Precis. Med. Com., vol. 3, no. 2, pp. 83–86, Dec. 2023, doi: 10.55627/pmc.003.02.0485.